ResearcherZhejiang Chinese Medical UniversityActive in the last 2 years
Biqin Tan
Matched on ORCID iD 0000-0002-2286-4489; OpenAlex author ID A5049175271. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 7
2020: 2 papers · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper
Papers 3
- AZD5153 enhances the chemo-sensitivity of gemcitabine on pancreatic cancer cells in vitro and in vivo. Co-author DOI 10.1186/s12935-025-03952-2↗
- The effect of ibrutinib on radiosensitivity in pancreatic cancer cells by targeting EGFR/AKT/mTOR signaling pathway. Co-author DOI 10.1016/j.biopha.2020.110133↗
- The Ibr-7 derivative of ibrutinib radiosensitizes pancreatic cancer cells by downregulating p-EGFR. Co-author DOI 10.1186/s12935-020-01548-6↗
Closest collaborators
The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Nengming Lin · 3 shared papers, 2020–2025 · strength 0.52
- Paper AZD5153 enhances the chemo-sensitivity of gemcitabine on pancreatic cancer cells in vitro and in vivo. DOI 10.1186/s12935-025-03952-2↗
- Paper The effect of ibrutinib on radiosensitivity in pancreatic cancer cells by targeting EGFR/AKT/mTOR signaling pathway. DOI 10.1016/j.biopha.2020.110133↗
- Paper The Ibr-7 derivative of ibrutinib radiosensitizes pancreatic cancer cells by downregulating p-EGFR. DOI 10.1186/s12935-020-01548-6↗
- Youyou Yan · 2 shared papers, 2020–2025 · strength 0.36
- Rong Dong · 2 shared papers, 2020–2025 · strength 0.36
- Lulin Zhu · 1 shared paper, 2025 · strength 0.23
- Bo Zhang · 1 shared paper, 2025 · strength 0.23
- Fei Wang · 1 shared paper, 2020 · strength 0.13
- Bo Zhang · 1 shared paper, 2020 · strength 0.13
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.